T1	Participants 423 557	Thirty-five healthy adults age 35-69 years were enrolled in a randomized, double-blind, placebo-controlled trial of 8 weeks' duration.
T2	Participants 558 574	All participants
T3	Participants 621 659	Nineteen participants received gelcaps
T4	Participants 749 781	16 participants received gelcaps
